NCT07501845Recruiting
Registry Maastro Applicator
Prospective Data Collection Initiative on MAASTRO HDR Rectal Applicator Treatments - a Prospective Observational Cohort Study.
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
This registry will collect data from all patients treated with the MAASTRO HDR applicator. The goal is to deepen knowledge about dose-response relationships in rectal cancer boosting, which is essential for improving future treatment approaches and patient selection.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 999 (estimated)
- First submitted
- 12 Mar 2026
- Start date
- 23 Mar 2026
- Primary completion date
- 1 Apr 2034
- Lead sponsor
- Maastricht Radiation Oncology
- Diseases
- Colorectal cancer
- NCT number
- NCT07501845
What you commit to
- Study type: Observational
- Planned participants: 999
- From 23 Mar 2026 to the primary completion date, 1 Apr 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Mentally incompetent patients.
Who the study is looking for
- Age ≥ 18 years.
- Histological proof of rectal cancer, or a strong suspicion after imaging.
- Treatment with MAASTRO HDR rectal applicator
- Informed consent for longitudinal observational data collection.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maastro Coordinator of this site? Confirm its status | Maastricht | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.